Federico Caligaris‐Cappio

Author

Also Known As

Caligaris-Cappio F, Caligaris-Cappio, Federico, Caligaris-Cappio, Federico 1948-, F CALIGARIS-CAPPIO, F CALIGARISCAPPIO, F Caligaris-Cappio, F. CALIGARIS-CAPPIO, F. Caligaris-Cappio, F. Caligaris-cappio, F. Caligaris‐Cappio

330

Publications

23.3K

Citations

H-Index

Concepts

All Affiliations

Vita-Salute San Raffaele University University of Turin San Raffaele University of Rome IRCCS Ospedale San Raffaele Istituti di Ricovero e Cura a Carattere Scientifico

About

Federico Caligaris‐Cappio is an author at Vita-Salute San Raffaele University specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	50	6K
2	Cell Biology	25	31	1.9K
3	Health Sciences	9	9	3.3K
4	Allergy	2	2	72
5	Biomedical Engineering	1	1	88

Federico Caligaris‐Cappio

127

Publications

19.5K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines Michael Hallek, Bruce D. Cheson, Daniel Catovsky, Blood	2008	3.2K
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial Michael Hallek, Kirsten Fischer, Guenter Fingerle-Rowson, The Lancet Hematological MalignancyLymphoid NeoplasiaOncologyChronic Lymphocytic LeukaemiaImmunology	2010	1.9K
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL Michael Hallek, Bruce D. Cheson, Daniel Catovsky, Blood	2018	1.6K
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia John C. Byrd, Jennifer R. Brown, Susan O’Brien, New England Journal of Medicine	2014	1.6K
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial Andrés JM Ferreri, Michele Reni, Marco Foppoli, The Lancet Hematological MalignancyNeuro-oncologyLymphoid NeoplasiaMedicinePrimary Cns Lymphoma	2009	656
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations Chrysoula Belessi, Carol Moreno, Myriam Boudjograh, Blood	2006	528
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia Andy C. Rawstron, Neus Villamor, Matthias Ritgen, Leukemia Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukaemiaMedicineMalignant Blood Disorder	2007	396
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia Luisa Granziero, Paolo Ghia, Paola Circosta, Blood	2001	335
Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis Fiona Murray, Nikos Darzentas, Anastasia Hadzidimitriou, Blood	2007	328
Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers Francesca Cottini, Teru Hideshima, Chunxiao Xu, Nature Medicine	2014	308

Page 1